Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
accrual, adenocarcinoma, antibody, antineoplastic, arisen, BeiGene, biliary, biparatopic, bispecific, breast, broader, BTC, chrysanthemi, clearance, Colorado, colorectal, commensurate, Connecticut, counterclaim, CPPA, CPRA, deceptive, excise, France, gastroesophageal, GEA, Germany, honor, HSR, inflationary, IRA, Kingdom, monopolization, palbociclib, Parkinson, post, power, readout, Rodino, scheme, Sherman, simultaneously, Spain, stronger, tract, untreated, Utah, Virginia, website, zanidatamab
Removed:
live, mutant, raf, Ras, Redx, uncontrolled
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view